Cargando…
MON-591 Thyroid Function and Autoimmunity Status after One and Three Months of Radioactive Iodine Therapy for Thyrotoxicosis
Background Radioioactive iodine therapy (RAI) is an excellent choice to treat thyrotoxicosis, particularly Graves´ disease (GD) patients. TSH receptor antibodies (TRAb) rise in GD patients and autoimmunity can surge after RAI. Objective Evaluate thyroid hormone function and autoimmunity 1 and 3 mont...
Autores principales: | Irigoitia, Bruna, Brito, Luciana, Lima Neto, Nicolau, Rocha, Nelisa, Watanabe, Tomoco, Marui, Suemi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550608/ http://dx.doi.org/10.1210/js.2019-MON-591 |
Ejemplares similares
-
SAT-410 Long Term Evaluation of TSH Receptor Antibodies and Thyroid Stimulating Immunoglobulin After Radioiodine Therapy for Thyrotoxicosis
por: Marui, Suemi, et al.
Publicado: (2020) -
SAT-415 Clinical Performance of Thyroid-Stimulating Immunoglobulin for Graves′ Disease Diagnosis
por: Marui, Suemi, et al.
Publicado: (2020) -
MON-481 Remarkable Euthyroid Hyperthyroxinemia Mistaken for Thyrotoxicosis
por: Baghel, Annavi, et al.
Publicado: (2020) -
Severe Thyrotoxicosis Following Topical Iodine Application
por: Coyne, Kasey, et al.
Publicado: (2021) -
MON-590 Outcomes Following Radioactive Iodine Therapy (RAI) in Hyperthyroid Patients with Grave’s Disease and Toxic Nodular Disease
por: Aljenaee, Khaled, et al.
Publicado: (2019)